<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01566825</url>
  </required_header>
  <id_info>
    <org_study_id>AVDT</org_study_id>
    <nct_id>NCT01566825</nct_id>
  </id_info>
  <brief_title>The Influence of Amitriptyline on Learning in a Visual Discrimination Task</brief_title>
  <official_title>The Influence of Amitriptyline (Amitriptylin-CT 25 mg®) on Learning in a Visual Discrimination Task (Karni-Sagi-paradigm)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dieter Kunz, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether 75 mg amitriptyline affect the sleep&#xD;
      dependent consolidation of procedural memory (visual discrimination task,&#xD;
      Karni-Sagi-paradigm).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rapid eye movement (REM) sleep is considered critical to the consolidation of procedural&#xD;
      memory - the memory of skills and habits. Many antidepressants strongly suppress REM sleep,&#xD;
      however, and procedural memory consolidation has been shown to be impaired in depressed&#xD;
      patients on antidepressant therapy. As a result, it is important to determine whether&#xD;
      antidepressive therapy can lead to amnestic impairment. We thus investigate the effects of&#xD;
      the anticholinergic antidepressant amitriptyline on sleep-dependent memory consolidation in&#xD;
      32 healthy men in a double-blind, placebo-controlled, randomized parallel-group study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in the visual discrimination task's perception threshold</measure>
    <time_frame>The visual discrimination task's perception treshold is assessed before sleep (day 10 at 6 pm) and after sleep (day 11 at 6 pm).</time_frame>
    <description>Improvement in this task is defined as a decrease in the perception threshold between training and retrieval testing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>amount of rapid eye movement (REM) sleep (sleep period time percentage)</measure>
    <time_frame>night from day 10 to day 11</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>Amitriptyline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>white 8 mm Lichtenstein®</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amitriptyline</intervention_name>
    <description>amitriptyline 25 mg at 9:30 pm, day 10, and 50 mg at 1:30 am, day 11</description>
    <arm_group_label>Amitriptyline</arm_group_label>
    <other_name>Saroten</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo(white 8 mm Lichtenstein®) at 9:30 pm, day 10, and at 1:30 am, day 11</description>
    <arm_group_label>white 8 mm Lichtenstein®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male gender&#xD;
&#xD;
          -  age 18 through 40 years&#xD;
&#xD;
          -  ability to communicate effectively in German&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  shift work within the past 24 months&#xD;
&#xD;
          -  any sleep disorder as measured by the Pittsburgh Sleep Quality Index&#xD;
&#xD;
          -  irregular sleep/wake patterns or extreme chronotype as measured by the&#xD;
             Morningness-Eveningness Questionnaire&#xD;
&#xD;
          -  history of any neurologic or psychiatric disorders&#xD;
&#xD;
          -  regular medication intake within the past four weeks&#xD;
&#xD;
          -  contraindications for amitriptyline&#xD;
&#xD;
          -  abnormal electrocardiogram (ECG)&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dieter Kunz, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dieter Kunz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin, Department of Physiology CBF</name>
      <address>
        <city>Berlin</city>
        <zip>10115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <study_first_submitted>March 27, 2012</study_first_submitted>
  <study_first_submitted_qc>March 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2012</study_first_posted>
  <last_update_submitted>March 27, 2012</last_update_submitted>
  <last_update_submitted_qc>March 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Dieter Kunz, MD</investigator_full_name>
    <investigator_title>Director of the Research Group Sleep Research and Clinical Chronobiology, Department of Physiology CBF, Charité - Universitätsmedizin Berlin</investigator_title>
  </responsible_party>
  <keyword>amitriptyline</keyword>
  <keyword>sleep dependent memory consolidation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amitriptyline</mesh_term>
    <mesh_term>Amitriptyline, perphenazine drug combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

